Regeneron Pharmaceuticals (REGN) 402.40 $REGN
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Regeneron Announces Upcoming 2015 Investor Conference Presentations
PR Newswire - Fri Feb 13, 8:30AM CST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:
REGN: 402.40 (+0.66)
The 10 Most Overpaid CEOs Running Multi-Billion Dollar Companies
at The Street - Fri Feb 13, 8:22AM CST
Which CEOs have the most egregious pay packages?
VIA: 69.08 (+1.02), MCK: 224.89 (+0.12), NBR: 12.73 (+0.52), FCX: 20.29 (+0.82), DISCA: 31.45 (+1.11), DIS: 104.17 (+0.59), CVS: 102.63 (-0.37), REGN: 402.40 (+0.66), ORCL: 43.93 (+0.04), CBS: 59.83 (+2.06)
'Mad Money' Lightning Round: Just Say No to Conoco Stock
at The Street - Fri Feb 13, 5:00AM CST
Cramer wants to own FreshPet and prefers Pepsico over Dr Pepper Snapple.
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), CELG: 115.88 (+0.16), PEP: 99.13 (-1.14), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), REGN: 402.40 (+0.66)
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Buy the Best and Leave the Rest
at The Street - Thu Feb 12, 7:12PM CST
Rarely does the market put the winning lottery ticket right in front of you, but today's winners were hiding in plain sight, Cramer says.
WFM: 56.15 (-0.15), MLM: 145.23 (+3.15),
72.91 (-0.81), TSLA: 203.77 (+0.89), FRPT: 16.78 (-0.12), SKX: 66.09 (-0.06), TRIP: 84.81 (+2.41), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), OWW: 11.68 (-0.04), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), WWAV: 38.65 (+0.61), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), EXPE: 89.49 (-0.08), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03)
Why Regeneron's Risk-Reward Looks Good Again
DoctoRx - at Seeking Alpha - Thu Feb 12, 12:43PM CST
PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), AMGN: 153.48 (+0.30), LLY: 70.56 (+0.03), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Forget Gilead Sciences: Here Are 3 Better Biotech Stocks
Motley Fool Staff - Motley Fool - Thu Feb 12, 7:19AM CST
A doubling of Gilead Sciences ' sales has given investors plenty of reason to cheer on the biotech Goliath over the past year. However, with Gilead Sciences' sales growth set to slow this year, investors may find that these three top biotech stocks...
BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), VIA: 69.08 (+1.02), ETP: 60.17 (+0.96), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), KEY: 14.11 (-0.08), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), ETP: 60.17 (+0.96), STI: 41.57 (+0.01), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Biotech Stocks: What's Hot, What's Not - As Seen By Market-Makers, Their Clients
Peter F. Way, CFA - at Seeking Alpha - Wed Feb 11, 11:37AM CST
MDVN: 104.71 (+0.67), BLUE: 90.70 (+0.93), BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ALXN: 182.29 (+6.02), TGTX: 13.13 (-0.19), TKMR: 21.45 (-0.22), ANAC: 40.76 (-0.07), PBYI: 205.26 (+2.75), REGN: 402.40 (+0.66)
Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Feb 11, 10:47AM CST
The hepatitis C virus (HCV) market remains in focus with Achillion (ACHN) presenting encouraging data.
GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), ABBV: 58.05 (+1.00), ALKS: 71.40 (-1.89), REGN: 402.40 (+0.66), XNPT: 6.69 (-0.21), CELG: 115.88 (+0.16)
'Mad Money' Lightning Round: Stop Fretting and Buy, Buy, Buy Sirius XM
at The Street - Wed Feb 11, 5:00AM CST
Cramer says stick with Taser and take UnitedHealth or Humana over HMS Holdings.
BAX: 70.39 (+0.31), ACHN: 10.89 (-0.20), UNH: 109.44 (-0.40), SYY: 39.54 (-0.12), TASR: 26.96 (-0.42), HMSY: 20.00 (+0.38), SIRI: 3.83 (-0.07), REGN: 402.40 (+0.66), HUM: 152.67 (-1.06), CELG: 115.88 (+0.16)
Baxter Needs To Split Up - Cramer's Lightning Round (2/10/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Wed Feb 11, 4:28AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, February 10. Bullish Calls: Achillion Pharmaceuticals (NASDAQ: ACHN ): " We have said it's a decent spec off of another Hep C," said Cramer....
CI: 114.47 (-0.51), BAX: 70.39 (+0.31), ACHN: 10.89 (-0.20), UNH: 109.44 (-0.40), SYY: 39.54 (-0.12), HMSY: 20.00 (+0.38), TASR: 26.96 (-0.42), SIRI: 3.83 (-0.07), REGN: 402.40 (+0.66), HUM: 152.67 (-1.06), CELG: 115.88 (+0.16)
Jim Cramer's 'Mad Money' Recap: No Foreign News Is Great U.S. News
at The Street - Tue Feb 10, 7:35PM CST
With no distractions, the U.S stock market rallied on a slew of terrific company news.
BIIB: 391.66 (-0.45), UNH: 109.44 (-0.40), SYY: 39.54 (-0.12), HOT: 78.55 (+0.67), HUM: 152.67 (-1.06), SBUX: 91.58 (-0.24), SAVE: 79.32 (-0.80), MAT: 27.61 (+0.17), CMG: 674.89 (+4.60), TASR: 26.96 (-0.42), REGN: 402.40 (+0.66), SIRI: 3.83 (-0.07), KO: 41.99 (-0.18), HAS: 62.74 (+0.58), DIS: 104.17 (+0.59), ALKS: 71.40 (-1.89), MAS: 26.45 (+0.02), ARO: 3.63 (+0.04), CELG: 115.88 (+0.16), URBN: 38.47 (+0.27), BAX: 70.39 (+0.31), ACHN: 10.89 (-0.20), GM: 37.62 (-0.40), YELP: 47.53 (-0.10), HMSY: 20.00 (+0.38)
Regeneron: Mixed Earnings, But A Leg Up In The Cholesterol Race
Kanak Kanti De - at Seeking Alpha - Tue Feb 10, 2:03PM CST
REGN: 402.40 (+0.66)
Regeneron Pharmaceuticals (REGN) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Tue Feb 10, 10:56AM CST
The following Regeneron Pharmaceuticals (REGN) conference call took place on February 10, 2015, 08:30 AM ET. This is a transcript of that earnings call:
REGN: 402.40 (+0.66)
Regeneron Pharmaceuticals Inc. Earnings: All Eyes on Eylea
George Budwell, The Motley Fool - Motley Fool - Tue Feb 10, 10:35AM CST
Regeneron Pharmaceuticals reported its fourth-quarter numbers before the bell this morning, slightly missing consensus on diluted earnings per share but beating on revenue. The Street expected diluted EPS of $2.82, but the company posted...
SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea
at Investor's Business Daily - Tue Feb 10, 10:01AM CST
Regeneron Pharmaceuticals (REGN) reported weaker-than-expected fourth-quarter earnings Tuesday morning, but the large-cap biotech topped sales views and offered an upbeat outlook for its blockbuster Eylea eye drug, which generates well more than half...
CBPO: 69.12 (+0.42), BIIB: 391.66 (-0.45), INSY: 51.50 (-0.66), PCYC: 163.28 (+0.23), BMRN: 100.76 (+1.98), AMGN: 153.48 (+0.30), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66), CELG: 115.88 (+0.16)
Seeking Alpha's Biotech Weekly: Crush-Proof Pfizer, Achillion's HCV Crusher, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 13, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
VRX: 167.00 (-0.50), ACT: 285.37 (+3.71), MDT: 75.26 (+0.33), XON: 39.30 (+1.05), CTIC: 2.23 (-0.02), PFNX: 12.45 (+0.29), JNJ: 99.62 (+1.18), ANTM: 141.05 (-0.95), NVAX: 8.80 (+0.40), SHPG: 239.82 (+6.11), ABBV: 58.05 (+1.00), TBPH: 18.51 (+0.28), SNY: 49.42 (+0.82), ALQA: 6.14 (+0.09), REGN: 402.40 (+0.66), ONCY: 0.51 (+0.02), PFE: 34.64 (-0.23), SLXP: 152.35 (+3.17), EPRS: 7.67 (+0.67), AMGN: 153.48 (+0.30), NKTR: 13.54 (-0.14), ZTS: 45.46 (-0.33), GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), GERN: 3.03 (unch)
Regeneron Announces Upcoming 2015 Investor Conference Presentations
PR Newswire - Fri Feb 13, 8:30AM CST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management presentations at the following investor conferences:
REGN: 402.40 (+0.66)
The 10 Most Overpaid CEOs Running Multi-Billion Dollar Companies
at The Street - Fri Feb 13, 8:22AM CST
Which CEOs have the most egregious pay packages?
VIA: 69.08 (+1.02), MCK: 224.89 (+0.12), NBR: 12.73 (+0.52), FCX: 20.29 (+0.82), DISCA: 31.45 (+1.11), DIS: 104.17 (+0.59), CVS: 102.63 (-0.37), REGN: 402.40 (+0.66), ORCL: 43.93 (+0.04), CBS: 59.83 (+2.06)
'Mad Money' Lightning Round: Just Say No to Conoco Stock
at The Street - Fri Feb 13, 5:00AM CST
Cramer wants to own FreshPet and prefers Pepsico over Dr Pepper Snapple.
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), CELG: 115.88 (+0.16), PEP: 99.13 (-1.14), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), REGN: 402.40 (+0.66)
Disney Is A Long-Term Buy - Cramer's Lightning Round (2/12/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Fri Feb 13, 4:32AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Thursday, February 12. Bullish Calls: Xerox (NYSE: XRX ): "The last quarter was not good and the stock should have gone down," said Cramer. He thinks...
FRPT: 16.78 (-0.12), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), DPS: 76.95 (-1.35), ZTS: 45.46 (-0.33), HALO: 14.73 (+0.23), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), MRK: 58.81 (-0.07), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Buy the Best and Leave the Rest
at The Street - Thu Feb 12, 7:12PM CST
Rarely does the market put the winning lottery ticket right in front of you, but today's winners were hiding in plain sight, Cramer says.
WFM: 56.15 (-0.15), MLM: 145.23 (+3.15),
72.91 (-0.81), TSLA: 203.77 (+0.89), FRPT: 16.78 (-0.12), SKX: 66.09 (-0.06), TRIP: 84.81 (+2.41), COP: 69.88 (+1.84), DIS: 104.17 (+0.59), XRX: 13.77 (+0.20), OWW: 11.68 (-0.04), PEP: 99.13 (-1.14), CELG: 115.88 (+0.16), WWAV: 38.65 (+0.61), DPS: 76.95 (-1.35), ISIS: 63.86 (-0.43), TSRA: 39.27 (-0.05), EXPE: 89.49 (-0.08), JUNO: 40.52 (+0.18), SPLK: 64.18 (+2.25), DATA: 99.90 (+1.40), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03) Why Regeneron's Risk-Reward Looks Good Again
DoctoRx - at Seeking Alpha - Thu Feb 12, 12:43PM CST
PFE: 34.64 (-0.23), AZN: 69.96 (+0.20), AMGN: 153.48 (+0.30), LLY: 70.56 (+0.03), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Forget Gilead Sciences: Here Are 3 Better Biotech Stocks
Motley Fool Staff - Motley Fool - Thu Feb 12, 7:19AM CST
A doubling of Gilead Sciences ' sales has given investors plenty of reason to cheer on the biotech Goliath over the past year. However, with Gilead Sciences' sales growth set to slow this year, investors may find that these three top biotech stocks...
BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), AMGN: 153.48 (+0.30), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Regional Banks Are The Way To Go - Cramer's Lightning Round (2/11/15)
SA Editor Mohit Manghnani - Seeking Alpha - Thu Feb 12, 5:05AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Wednesday, February 11. Bullish Calls: HomeAway (NASDAQ: AWAY ): "The stock market is saying it is overvalued but I think don't give up on CEO Brian." ...
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), VIA: 69.08 (+1.02), ETP: 60.17 (+0.96), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
'Mad Money' Lightning Round: Buy, Buy, Buy Boeing Below $140
at The Street - Thu Feb 12, 5:00AM CST
Cramer says don't give up on HomeAway, Quanta Services is too risk but Acadia Healthcare is terrific.
ACHC: 63.20 (-0.45), KMI: 41.97 (+0.21), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), AWAY: 29.68 (+0.11), BBT: 38.28 (-0.04), PWR: 28.76 (-0.10), AMGN: 153.48 (+0.30), KEY: 14.11 (-0.08), BA: 149.73 (+1.64), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), CELG: 115.88 (+0.16), ETP: 60.17 (+0.96), STI: 41.57 (+0.01), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), REGN: 402.40 (+0.66)
Jim Cramer's 'Mad Money' Recap: Get Ready to Profit on Europe-Induced Weakness
at The Street - Wed Feb 11, 7:14PM CST
Lots of investors are worried about Europe, Cramer says, but you don't have to be.
KMI: 41.97 (+0.21), ACHC: 63.20 (-0.45), FLEX: 12.05 (-0.09), GE: 25.15 (+0.26), BBT: 38.28 (-0.04), AWAY: 29.68 (+0.11), XOM: 93.37 (+1.00), KEY: 14.11 (-0.08), INTC: 34.36 (+0.23), AFFX: 11.45 (+0.02), TWX: 83.87 (+0.56), PEP: 99.13 (-1.14), AEP: 57.83 (-0.15), ETP: 60.17 (+0.96), CMG: 674.89 (+4.60), QLYS: 47.95 (+1.46), GOOGL: 551.16 (+5.15), MSFT: 43.87 (+0.78), HSIC: 143.18 (+0.72), AAPL: 127.08 (+0.62), REGN: 402.40 (+0.66), CSCO: 29.43 (-0.03), CY: 14.76 (+0.01), SWKS: 81.85 (-0.57), PWR: 28.76 (-0.10), FB: 75.74 (-0.49), PFE: 34.64 (-0.23), HAL: 44.19 (+1.42), AMGN: 153.48 (+0.30), BAC: 16.61 (-0.06), BMY: 60.04 (+0.56), BA: 149.73 (+1.64), HPQ: 38.56 (+0.19), RAD: 8.34 (+0.25), CELG: 115.88 (+0.16), ZTS: 45.46 (-0.33), UA: 73.76 (-0.19), AA: 15.81 (+0.16), GILD: 101.90 (+1.10), STI: 41.57 (+0.01), GM: 37.62 (-0.40), AGIO: 118.55 (+0.11), CRL: 73.61 (-0.33), FSL: 37.53 (+2.83), VIAB: 68.98 (+1.27), CL: 70.08 (+0.23)
Biotech Stocks: What's Hot, What's Not - As Seen By Market-Makers, Their Clients
Peter F. Way, CFA - at Seeking Alpha - Wed Feb 11, 11:37AM CST
MDVN: 104.71 (+0.67), BLUE: 90.70 (+0.93), BIIB: 391.66 (-0.45), GILD: 101.90 (+1.10), ALXN: 182.29 (+6.02), TGTX: 13.13 (-0.19), TKMR: 21.45 (-0.22), ANAC: 40.76 (-0.07), PBYI: 205.26 (+2.75), REGN: 402.40 (+0.66)
Biotech Stock Roundup: Achillion Impresses with HCV Data, Regeneron 4Q Results Top Estimates - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Feb 11, 10:47AM CST
The hepatitis C virus (HCV) market remains in focus with Achillion (ACHN) presenting encouraging data.
GILD: 101.90 (+1.10), ACHN: 10.89 (-0.20), ABBV: 58.05 (+1.00), ALKS: 71.40 (-1.89), REGN: 402.40 (+0.66), XNPT: 6.69 (-0.21), CELG: 115.88 (+0.16)
'Mad Money' Lightning Round: Stop Fretting and Buy, Buy, Buy Sirius XM
at The Street - Wed Feb 11, 5:00AM CST
Cramer says stick with Taser and take UnitedHealth or Humana over HMS Holdings.
BAX: 70.39 (+0.31), ACHN: 10.89 (-0.20), UNH: 109.44 (-0.40), SYY: 39.54 (-0.12), TASR: 26.96 (-0.42), HMSY: 20.00 (+0.38), SIRI: 3.83 (-0.07), REGN: 402.40 (+0.66), HUM: 152.67 (-1.06), CELG: 115.88 (+0.16)
Baxter Needs To Split Up - Cramer's Lightning Round (2/10/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Wed Feb 11, 4:28AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, February 10. Bullish Calls: Achillion Pharmaceuticals (NASDAQ: ACHN ): " We have said it's a decent spec off of another Hep C," said Cramer....
CI: 114.47 (-0.51), BAX: 70.39 (+0.31), ACHN: 10.89 (-0.20), UNH: 109.44 (-0.40), SYY: 39.54 (-0.12), HMSY: 20.00 (+0.38), TASR: 26.96 (-0.42), SIRI: 3.83 (-0.07), REGN: 402.40 (+0.66), HUM: 152.67 (-1.06), CELG: 115.88 (+0.16)
Jim Cramer's 'Mad Money' Recap: No Foreign News Is Great U.S. News
at The Street - Tue Feb 10, 7:35PM CST
With no distractions, the U.S stock market rallied on a slew of terrific company news.
BIIB: 391.66 (-0.45), UNH: 109.44 (-0.40), SYY: 39.54 (-0.12), HOT: 78.55 (+0.67), HUM: 152.67 (-1.06), SBUX: 91.58 (-0.24), SAVE: 79.32 (-0.80), MAT: 27.61 (+0.17), CMG: 674.89 (+4.60), TASR: 26.96 (-0.42), REGN: 402.40 (+0.66), SIRI: 3.83 (-0.07), KO: 41.99 (-0.18), HAS: 62.74 (+0.58), DIS: 104.17 (+0.59), ALKS: 71.40 (-1.89), MAS: 26.45 (+0.02), ARO: 3.63 (+0.04), CELG: 115.88 (+0.16), URBN: 38.47 (+0.27), BAX: 70.39 (+0.31), ACHN: 10.89 (-0.20), GM: 37.62 (-0.40), YELP: 47.53 (-0.10), HMSY: 20.00 (+0.38)
Regeneron: Mixed Earnings, But A Leg Up In The Cholesterol Race
Kanak Kanti De - at Seeking Alpha - Tue Feb 10, 2:03PM CST
REGN: 402.40 (+0.66)
Regeneron Pharmaceuticals (REGN) Earnings Report: Q4 2014 Conference Call Transcript
at The Street - Tue Feb 10, 10:56AM CST
The following Regeneron Pharmaceuticals (REGN) conference call took place on February 10, 2015, 08:30 AM ET. This is a transcript of that earnings call:
REGN: 402.40 (+0.66)
Regeneron Pharmaceuticals Inc. Earnings: All Eyes on Eylea
George Budwell, The Motley Fool - Motley Fool - Tue Feb 10, 10:35AM CST
Regeneron Pharmaceuticals reported its fourth-quarter numbers before the bell this morning, slightly missing consensus on diluted earnings per share but beating on revenue. The Street expected diluted EPS of $2.82, but the company posted...
SNY: 49.42 (+0.82), REGN: 402.40 (+0.66)
Regeneron Q4 Sales, 2015 Outlook Upbeat On Eylea
at Investor's Business Daily - Tue Feb 10, 10:01AM CST
Regeneron Pharmaceuticals (REGN) reported weaker-than-expected fourth-quarter earnings Tuesday morning, but the large-cap biotech topped sales views and offered an upbeat outlook for its blockbuster Eylea eye drug, which generates well more than half...
CBPO: 69.12 (+0.42), BIIB: 391.66 (-0.45), INSY: 51.50 (-0.66), PCYC: 163.28 (+0.23), BMRN: 100.76 (+1.98), AMGN: 153.48 (+0.30), SNY: 49.42 (+0.82), REGN: 402.40 (+0.66), CELG: 115.88 (+0.16)
